President orders review of psychiatric and weight-loss drugs for children
Image credit: diana_pole via Unsplash
The current U.S. president has initiated an executive action to study the use of psychiatric and weight-loss medications in children, claiming these drugs could pose risks. This move has provoked diverse reactions among medical experts who support the proven safety and effectiveness of these medications when properly prescribed. Leading organizations like the American Academy of Child and Adolescent Psychiatry and the American Academy of Pediatrics affirm that these medications are safe and effective. Additionally, they clarify that weight-loss medications should be prescribed alongside proper nutrition and a healthy lifestyle and are not typically the first line of treatment for children, challenging the concerns raised.
Source
Dwyer JB, Bloch MH. Antidepressants for Pediatric Patients. Curr Psychiatr. 2019 Sep;18(9):26-42F. PMID: 31511767; PMCID: PMC6738970.
Additional Reading
https://www.washingtonpost.com/health/2025/02/16/trump-psychiatric-medications-drugs-weight/
https://abcnews.go.com/Health/rfk-jr-studying-threat-ssris-weight-loss-drugs/story?id=118937552